Potential therapeutic and pharmacological strategies for SARS-CoV2

被引：0
|
作者：
Doaa A. Ghareeb
Samar R. Saleh
Mohammed S. Nofal
Mohamed M. Y. Kaddah
Salma. F. Hassan
Inas K. Seif
Sally A. El-Zahaby
Shaimaa M. Khedr
Marwa Y. Kenawy
Aliaa A. Masoud
Salma A. Soudi
Ahmed A. Sobhy
Jaillan G. Sery
Miral G. Abd El-Wahab
Alshimaa A. Abd Elmoneam
Abdulaziz Mohsen Al-mahallawi
Maha A. El-Demellawy
机构：
[1] Alexandria University,Biological Screening and Preclinical Trial Laboratory, Department of Biochemistry, Faculty of Science
[2] City of Scientific Research and Technological Applications (SRTA-City),Pharmaceutical and Fermentation Industries Development Centre (PFIDC)
[3] Pharos University in Alexandria,Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy
[4] City of Scientific Research and Technological Applications (SRTA-City),Fabrication Technology Department, Advanced Technology and New Materials Research Institute (ATNMRI)
[5] Alexandria University,Clinical Pharmacy Program, Faculty of Pharmacy
[6] Cairo University,Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy
[7] October University for Modern Sciences and Arts (MSA),Department of Pharmaceutics, Faculty of Pharmacy
[8] GEBRI,Medical Biotechnology Department
[9] SRTA-City,undefined
来源：
Journal of Pharmaceutical Investigation | 2021年 / 51卷
关键词：
COVID-19; Hydroxychloroquine; Indomethacin; Tocilizumab; Teicoplanin; Camostat;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：281 / 296
页数：15
相关论文
共 50 条
  • [21] Decreasing Potential Risk of Transfusion Transmitted Sars-CoV2 to Cancer Patients
    Moreira Lemos, Marta Maria
    Riegel, Eduardo Ernesto
    Gomes de Molla, Raissa Pavoni
    Colella, Marina Pereira
    Colella, Marcos Paulo
    Kayano, Sandra Satoe
    Colella, Rafael
    TRANSFUSION, 2020, 60 : 99A - 100A
  • [22] SARS-CoV2 S Protein Features Potential Estrogen Binding Site
    Tomasovic, Ante
    Stanzer, Damir
    Svetec, Ivan Kresimir
    Miklenic, Marina Svetec
    FOOD TECHNOLOGY AND BIOTECHNOLOGY, 2021, 59 (01) : 24 - 30
  • [23] Potential inactivation of SARS-CoV2 coronavirus: which germicidal agents are proposed?
    Wilches Visbal, Jorge Homero
    Castillo Pedraza, Midian Clara
    Serpa Romero, Xiomara Zilena
    REVISTA CUIDARTE, 2021, 12 (01)
  • [24] COVID-19 and chronic obstructive pulmonary disease: therapeutic potential of blocking SARS-CoV2 adhesion factors
    Shukla, Shakti D.
    Walters, E. Haydn
    INTERNAL MEDICINE JOURNAL, 2020, 50 (09) : 1153 - 1154
  • [25] Impact of the SARS-CoV2 Pandemic on Education
    Jimenez-Sanchez, Carlos
    REVISTA ELECTRONICA EDUCARE, 2020, 24
  • [26] Susceptibility of SARS-CoV2 infection in children
    Nicola Cotugno
    Donato Amodio
    Danilo Buonsenso
    Paolo Palma
    European Journal of Pediatrics, 2023, 182 : 4851 - 4857
  • [27] Neuroinvasive potential of a primary respiratory pathogen SARS-CoV2: Summarizing the evidences
    Lahiri, Durjoy
    Mondal, Ritwick
    Deb, Shramana
    Bandyopadhyay, Deebya
    Shome, Gourav
    Sarkar, Sukanya
    Biswas, Subhas C.
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2020, 14 (05) : 1053 - 1060
  • [28] SARS-CoV2 vaccine boosters for India
    Kang, Gagandeep
    INDIAN JOURNAL OF MEDICAL MICROBIOLOGY, 2022, 40 (01) : 1 - 2
  • [29] Neurological Involvements of SARS-CoV2 Infection
    Gasmi, Amin
    Tippairote, Torsak
    Mujawdiya, Pavan Kumar
    Gasmi Benahmed, Asma
    Menzel, Alain
    Dadar, Maryam
    Bjorklund, Geir
    MOLECULAR NEUROBIOLOGY, 2021, 58 (03) : 944 - 949
  • [30] Passive immunotherapy in Sars-Cov2 infections
    Christodoulou, Ioanna
    Cohen, Jacques H. M.
    VIROLOGIE, 2021, 25 (06) : 317 - 325
12345